首页 › 基金 › Soleus Capital Management, L.P. › UTHR

Soleus Capital Management, L.P. 对 UTHR 的持仓历史

UNITED THERAPEUTICS CORP DEL · 医疗保健

Soleus Capital Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 UTHR(UNITED THERAPEUTICS CORP DEL)259,000 股,市值约 US$140.3M,约占其申报组合的 4.99%,在其申报持仓中市值排名第 5 位。 Soleus Capital Management, L.P. 最近 13 个申报季度中有 13 个季度披露了 UTHR 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)259.00K 股
申报持仓市值$140.35M
组合权重4.99%
首次申报Q3 2023
最近变动增持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Soleus Capital Management, L.P. 对 UTHR 的持仓演变

Soleus Capital Management, L.P. 于 Q3 2023 首次披露 UTHR 持仓:287,165 股(约 US$64.9M)。 该持仓在 Q3 2026 达到峰值 259,000 股,市值约 US$140.3M。 在 13 次申报中,Soleus Capital Management, L.P. 7 次增持、5 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 259,000 股、市值约 US$140.3M,环比增持 33,413 股。。 持仓曾出现大幅变动:Q2 2024 减持约 46% (随后一个季度股价上涨 12%)、Q4 2025 减持约 60% (随后一个季度股价上涨 22%)、Q1 2026 增持约 212% (随后一个季度股价下跌 9%)。

逐季持仓明细

季度股数金额变化
Q3 2023 287.17K $64.86M 新进
Q4 2023 249.45K $54.85M 减持
Q1 2024 259.75K $59.67M 增持
Q2 2024 141.50K $45.07M 减持
Q3 2024 101.89K $36.51M 减持
Q4 2024 109.39K $38.60M 增持
Q1 2025 155.39K $47.90M 增持
Q2 2025 209.79K $60.28M 增持
Q3 2025 150.00K $62.88M 减持
Q4 2025 60.00K $29.23M 减持
Q1 2026 187.19K $111.00M 增持
Q2 2026 225.59K $122.23M 增持
Q3 2026 259.00K $140.35M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 UTHR 与 13F 数据

UTHR(UNITED THERAPEUTICS CORP DEL)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 UTHR,申报仓位最大的包括:Avoro Capital Advisors LLC (US$1.49B), 文艺复兴科技 (US$908.2M), ASSETMARK, INC (US$325.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 UTHR 的基金

查看 UTHR 的全部基金持有人 →

常见问题

How long has Soleus Capital Management, L.P. held UTHR?

Soleus Capital Management, L.P. has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Soleus Capital Management, L.P.'s current position in UTHR?

As of Q3 2026, Soleus Capital Management, L.P. holds 259.00K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $140.35M, representing 4.99% of its reported portfolio and ranking #5.

Has Soleus Capital Management, L.P. been buying or selling UTHR?

In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. increased its position in UTHR. The position peaked in Q3 2026 at 259.00K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, 文艺复兴科技, ASSETMARK, INC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.